Biomarkers Cancer Coronary Artery Disease 
Dr. Paddy Barrett
APRIL 26, 2024
Coronary artery disease is caused by the retention of a cholesterol particle in the artery wall. Insulin resistance and diabetes may not ‘ cause ’ coronary artery disease, but they are huge accelerants. If delaying the onset of major chronic disease is your goal. Timing Matters.
Dr. Paddy Barrett
OCTOBER 11, 2024
Inflammation is a key driver of heart disease, specifically coronary artery disease. I have covered this topic previously here , but it is clear that inflammation plays a major role in the initiation and progression of coronary artery disease, and the inflammatory biomarker hsCRP is tightly connected to this process.
Dr. Paddy Barrett
SEPTEMBER 13, 2024
Understanding where you sit on this continuum is a key part of defining your future risk of heart disease but also dementia, and many cancers. Even having one of the metabolic syndrome factors increases the risk of dying from heart disease by 73% 4. Metabolic syndrome can be assessed easily and cheaply in any healthcare setting.
Dr. Anish Koka
MAY 16, 2023
Diamond and Forrester accomplished this by first establishing the prevalence of coronary artery disease based on how clinically likely patients with chest pain symptoms were found to have coronary disease based on a coronary angiogram. Thanks for reading Dr. Anish Koka's Newsletter!
Circulation: Cardiovascular Imaging
FEBRUARY 19, 2024
18F-flourodeoxyglucose resting amygdalar uptake, an imaging biomarker of stress-related neural activity, coronary inflammation (fat attenuation index), and high-risk plaque characteristics were assessed by coronary computed tomography angiography. versus 5.1%; adjusted hazard ratio, 3.62 [95% CI, 1.14–17.14];P=0.039)
Expert insights. Personalized for you.
105 
Let's personalize your content